Search Results - "IGNATENKO, Natalia A"

Refine Results
  1. 1

    Specific microRNA–mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein–Related Peptidase 6 by Sells, Earlphia, Pandey, Ritu, Chen, Hwudaurw, Skovan, Bethany A, Cui, Haiyan, Ignatenko, Natalia A

    Published in Neoplasia (New York, N.Y.) (01-05-2017)
    “…Abstract Metastatic colon cancer is a major cause of deaths among colorectal cancer (CRC) patients. Elevated expression of kallikrein 6 (KLK6), a member of a…”
    Get full text
    Journal Article
  2. 2

    Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins by Marr, Kendra D, Ignatenko, Natalia A, Warfel, Noel A, Batai, Ken, Cress, Anne E, Pollock, Grant R, Wong, Ava C, Lee, Benjamin R

    Published in Frontiers in oncology (13-01-2023)
    “…The advent of perpetuating living organoids derived from patient tissue is a promising avenue for cancer research but is limited by difficulties with precise…”
    Get full text
    Journal Article
  3. 3

    Caveolin‐1 is a novel regulator of K‐RAS‐dependent migration in colon carcinogenesis by Basu Roy, Upal K., Henkhaus, Rebecca S., Loupakis, Fotios, Cremolini, Chiara, Gerner, Eugene W., Ignatenko, Natalia A.

    Published in International journal of cancer (01-07-2013)
    “…Caveolin‐1 is an essential component of membrane caveolae. It is an important regulator of cellular processes such as signal transduction and endocytosis. We…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Cyclooxygenase-independent Induction of Apoptosis by Sulindac Sulfone Is Mediated by Polyamines in Colon Cancer by Babbar, Naveen, Ignatenko, Natalia A, Casero, Jr, Robert A, Gerner, Eugene W

    Published in The Journal of biological chemistry (28-11-2003)
    “…Sulindac, a non-steroidal anti-inflammatory prodrug, is metabolized into pharmacologically active sulfide and sulfone derivatives. Sulindac sulfide, but not…”
    Get full text
    Journal Article
  6. 6

    Caveolin-1-Mediated Expression and Secretion of Kallikrein 6 in Colon Cancer Cells by Henkhaus, Rebecca S., Roy, Upal Kunal Basu, Cavallo-Medved, Dora, Sloane, Bonnie F., Gerner, Eugene W., Ignatenko, Natalia A.

    Published in Neoplasia (New York, N.Y.) (01-02-2008)
    “…Kallikreins are secreted proteases that may play a functional role and/or serve as a serum biomarker for the presence or progression of certain types of…”
    Get full text
    Journal Article
  7. 7

    Wild-type APC regulates caveolin-1 expression in human colon adenocarcinoma cell lines via FOXO1a and C-myc by Roy, Upal K. Basu, Henkhaus, Rebecca S., Ignatenko, Natalia A., Mora, Jessica, Fultz, Kimberly E., Gerner, Eugene W.

    Published in Molecular carcinogenesis (01-12-2008)
    “…Genetic evidence suggests that caveolin‐1, an essential component of membrane caveolae, acts as a tumor promoter in some, and a tumor suppressor in other…”
    Get full text
    Journal Article
  8. 8

    HuRrying colon cancer progression by Ignatenko, Natalia A., Gerner, Eugene W.

    Published in Cancer biology & therapy (01-03-2008)
    “…Commentary to: Increased expression of cytoplasmic HuR in familial adenomatous polyposis Lodewijk A.A. Brosens, Josbert J. Keller, Leena Pohjola, Caj Haglund,…”
    Get full text
    Journal Article
  9. 9

    Mutant K-RAS Promotes Invasion and Metastasis in Pancreatic Cancer Through GTPase Signaling Pathways by Padavano, Julianna, Henkhaus, Rebecca S., Chen, Hwudaurw, Skovan, Bethany A., Cui, Haiyan, Ignatenko, Natalia A.

    Published in Cancer Growth and Metastasis (01-01-2015)
    “…Pancreatic ductal adenocarcinoma is one of the most aggressive malignancies, characterized by the local invasion into surrounding tissues and early metastasis…”
    Get full text
    Journal Article
  10. 10

    Detection of Enzyme Activity and Inhibition during Studies in Solution, In Vitro and In Vivo with CatalyCEST MRI by Sinharay, Sanhita, Randtke, Edward A., Howison, Christine M., Ignatenko, Natalia A., Pagel, Mark D.

    Published in Molecular imaging and biology (01-04-2018)
    “…Purpose The detection of enzyme activities and evaluation of enzyme inhibitors have been challenging with magnetic resonance imaging (MRI). To address this…”
    Get full text
    Journal Article
  11. 11

    Kallikrein 6 protease advances colon tumorigenesis via induction of the high mobility group A2 protein by Chen, Hwudaurw, Sells, Earlphia, Pandey, Ritu, Abril, Edward R, Hsu, Chiu-Hsieh, Krouse, Robert S, Nagle, Raymond B, Pampalakis, Georgios, Sotiropoulou, Georgia, Ignatenko, Natalia A

    Published in Oncotarget (22-10-2019)
    “…Kallikrein-related peptidase 6 (KLK6) overexpression is commonly observed in primary tumors of colorectal cancer (CRC) patients and has been associated with…”
    Get full text
    Journal Article
  12. 12

    Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer by Pandey, Ritu, Zhou, Muhan, Chen, Yuliang, Darmoul, Dalila, Kisiel, Conner C., Nfonsam, Valentine N., Ignatenko, Natalia A.

    Published in Genes (16-05-2021)
    “…Colorectal cancer (CRC) remains one of the leading causes of cancer-related death worldwide. The high mortality of CRC is related to its ability to metastasize…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    A Comprehensive Strategy to Combat Colon Cancer Targeting the Adenomatous Polyposis Coli Tumor Suppressor Gene by GERNER, EUGENE W., IGNATENKO, NATALIA A., LANCE, PETER, HURLEY, LAURENCE H.

    Published in Annals of the New York Academy of Sciences (01-11-2005)
    “…: Somatic cells in the majority of colorectal polyps and cancers contain mutations/deletions in the adenomatous polyposis coli (APC) tumor suppressor gene. APC…”
    Get full text
    Journal Article
  16. 16

    Gene Expression Analysis of HCT116 Colon Tumor-derived Cells Treated with the Polyamine Analog PG-11047 by Ignatenko, Natalia A, Yerushalmi, Hagit F, Pandey, Ritu, Kachel, Karen L, Stringer, David E, Marton, Laurence J, Gerner, Eugene W

    Published in Cancer genomics & proteomics (01-05-2009)
    “…Background: The conformationally restricted polyamine analog PG-11047 has significant growth inhibitory activity against prostate and lung cancer cell lines…”
    Get full text
    Journal Article
  17. 17

    Influence of K-ras Activation on the Survival Responses of Caco-2 Cells to the Chemopreventive Agents Sulindac and Difluoromethylornithine by LAWSON, Kathryn R, IGNATENKO, Natalia A, PIAZZA, Gary A, CUI, Hiayan, GERNER, Eugene W

    “…The nonsteroidal anti-inflammatory drug sulindac and the ornithine decarboxylase inhibitor difluoromethylornithine (DFMO) are both potent inhibitors of colon…”
    Get full text
    Journal Article
  18. 18

    Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells by Henkhaus, Rebecca S, Gerner, Eugene W, Ignatenko, Natalia A

    Published in Biological chemistry (01-06-2008)
    “…Kallikrein 6 (KLK6) is a trypsin-like serine peptidase whose relevance in various types of cancers is currently being explored. Previous studies have shown…”
    Get more information
    Journal Article
  19. 19

    Does Mutated K-RAS Oncogene Attenuate the Effect of Sulindac in Colon Cancer Chemoprevention? by Rice, Photini F S, Ehrichs, Kevin G, Jones, Mykella S, Chen, Hwudarw, Hsu, Chiu-Hsieh, Abril, Edward R, Nagle, Raymond B, Besselsen, David G, Barton, Jennifer K, Ignatenko, Natalia A

    “…The NSAID sulindac has been successfully used alone or in combination with other agents to suppress colon tumorigenesis in patients with genetic predisposition…”
    Get full text
    Journal Article
  20. 20

    Get the Fat Out by IGNATENKO, Natalia A, GERNER, Eugene W

    “…Obesity is associated with increased risk of a number of cancers in humans, but the mechanism(s) responsible for these associations have not been established…”
    Get full text
    Journal Article